Neurotransmission systems in Parkinson's disease
H Sanjari Moghaddam, A Zare-Shahabadi… - Reviews in the …, 2017 - degruyter.com
Parkinson's disease (PD) is histologically characterized by the accumulation of α-synuclein
particles, known as Lewy bodies. The second most common neurodegenerative disorder …
particles, known as Lewy bodies. The second most common neurodegenerative disorder …
Neurotransmission in Parkinson's disease: beyond dopamine
P Barone - European journal of neurology, 2010 - Wiley Online Library
Parkinson's disease (PD) is most frequently associated with characteristic motor symptoms
that are known to arise with degeneration of dopaminergic neurons. However, patients with …
that are known to arise with degeneration of dopaminergic neurons. However, patients with …
The nonmotor features of Parkinson's disease: pathophysiology and management advances
H Reichmann, MD Brandt… - Current opinion in …, 2016 - journals.lww.com
The nonmotor features of Parkinson's disease: pathophysiolog... : Current Opinion in
Neurology The nonmotor features of Parkinson's disease: pathophysiology and …
Neurology The nonmotor features of Parkinson's disease: pathophysiology and …
Glymphatic system dysfunction and sleep disturbance may contribute to the pathogenesis and progression of Parkinson's disease
A Massey, MK Boag, A Magnier, DPCF Bispo… - International journal of …, 2022 - mdpi.com
Parkinson's disease (PD) is a multisystem alpha-synucleinopathic neurodegenerative
disease and the most prevalent neurodegenerative disorder after Alzheimer's disease with a …
disease and the most prevalent neurodegenerative disorder after Alzheimer's disease with a …
Functional changes of the basal ganglia circuitry in Parkinson's disease
F Blandini, G Nappi, C Tassorelli, E Martignoni - Progress in neurobiology, 2000 - Elsevier
The basal ganglia circuitry processes the signals that flow from the cortex, allowing the
correct execution of voluntary movements. In Parkinson's disease, the degeneration of …
correct execution of voluntary movements. In Parkinson's disease, the degeneration of …
Neuronal networks and synaptic plasticity in Parkinson's disease: beyond motor deficits
P Calabresi, F Galletti, E Saggese, V Ghiglieri… - Parkinsonism & related …, 2007 - Elsevier
The excitatory corticostriatal pathway, which plays a critical role in the building up and
storage of adaptive motor behaviours, can undergo long-lasting, activity-dependent changes …
storage of adaptive motor behaviours, can undergo long-lasting, activity-dependent changes …
Electrophysiology of dopamine in normal and denervated striatal neurons
P Calabresi, D Centonze, G Bernardi - Trends in neurosciences, 2000 - cell.com
Parkinson's disease (PD) symptoms originate from the loss of the dopaminergic control of
neuronal activity in the striatum. Permanent loss of dopaminergic terminals in the striatum …
neuronal activity in the striatum. Permanent loss of dopaminergic terminals in the striatum …
[PDF][PDF] Classical neurotransmitters and neuropeptides involved in Parkinson's Disease: A multi-neurotransmitter system
FM Werner, R Coveñas - Journal of Cytology & Histology, 2014 - pdfs.semanticscholar.org
Parkinson's disease is a neurodegenerative disease with motor and non-motor symptoms. In
Parkinson's disease, a neurotransmitter imbalance occurs in the extrapyramidal system with …
Parkinson's disease, a neurotransmitter imbalance occurs in the extrapyramidal system with …
Understanding multifactorial architecture of Parkinson's disease: pathophysiology to management
Parkinson's disease (PD) is the second most common multifactorial neurodegenerative
disorder affecting 3% of population during elder age. The loss of substantia nigra, pars …
disorder affecting 3% of population during elder age. The loss of substantia nigra, pars …
Biochemical aspects of Parkinson's disease
O Hornykiewicz - Neurology, 1998 - AAN Enterprises
The importance of the striatal dopamine (DA) deficiency and the DA substituting property of
levodopa for the pathophysiology and therapy of Parkinson's disease (PD) is reiterated. In …
levodopa for the pathophysiology and therapy of Parkinson's disease (PD) is reiterated. In …